Deepali Kumar to Antiviral Agents
This is a "connection" page, showing publications Deepali Kumar has written about Antiviral Agents.
Connection Strength
0.090
-
A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients. Clin Infect Dis. 2018 10 15; 67(9):1322-1329.
Score: 0.018
-
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation. 2018 06; 102(6):900-931.
Score: 0.018
-
Letermovir Prophylaxis for Cytomegalovirus. N Engl J Med. 2018 03 08; 378(10):963-4.
Score: 0.017
-
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection. PLoS Pathog. 2017 Apr; 13(4):e1006299.
Score: 0.016
-
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir Med. 2021 05; 9(5):498-510.
Score: 0.005
-
Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation. N Engl J Med. 2020 09 17; 383(12):1168-1180.
Score: 0.005
-
Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS). Clin Infect Dis. 2020 08 22; 71(5):1186-1194.
Score: 0.005
-
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis. Clin Infect Dis. 2018 02 01; 66(4):617-631.
Score: 0.004